Befejeződött1. fázis
A study of enfortumab vedotin given in the bladder for treatment of patients with non-muscle invasive bladder cancer (NMIBC).
Key facts
- Where
- Barcelona és Madrid, SpanyolországSee the 4 sites
- Phase
- 1. fázis
Where in Spanyolország
- Fundació PuigvertBarcelona, SpanyolországNo longer taking part
- Hospital Clinic de BarcelonaBarcelona, SpanyolországNo longer taking part
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
- Hospital Universitario 12 de OctubreMadrid, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Seagen Inc.
- Trial code
- EU 2023-503388-40-00
- Record updated
- 2025. április 2.